Isabel Poschke

4.2k total citations
49 papers, 2.7k citations indexed

About

Isabel Poschke is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Isabel Poschke has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 32 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Isabel Poschke's work include Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (16 papers). Isabel Poschke is often cited by papers focused on Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (16 papers). Isabel Poschke collaborates with scholars based in Germany, Sweden and United States. Isabel Poschke's co-authors include Rolf Kiessling, Giuseppe Masucci, Dimitrios Mougiakakos, Johan Hansson, Yumeng Mao, Håkan Norell, Jana de Boniface, Yago Pico de Coaña, Andreas Lundqvist and Karl‐Johan Malmberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Isabel Poschke

47 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Poschke Germany	27	2.1k	1.5k	573	145	113	49	2.7k
Helena Harlin United States	16	1.6k 0.8×	1.3k 0.9×	742 1.3×	185 1.3×	90 0.8×	25	2.4k
Armelle Prévost‐Blondel France	27	1.8k 0.9×	1.4k 0.9×	672 1.2×	253 1.7×	102 0.9×	46	2.7k
Adrienne Luoma United States	20	1.8k 0.9×	1.4k 0.9×	902 1.6×	205 1.4×	86 0.8×	25	3.0k
Cristina Maccalli Italy	27	1.8k 0.9×	1.9k 1.2×	754 1.3×	355 2.4×	203 1.8×	61	2.8k
David Y. Oh United States	18	1.1k 0.5×	1.0k 0.7×	918 1.6×	171 1.2×	95 0.8×	43	2.4k
Rebekka Weber Germany	15	1.6k 0.8×	1.2k 0.7×	620 1.1×	240 1.7×	173 1.5×	16	2.2k
Minu K. Srivastava United States	18	1.3k 0.6×	960 0.6×	480 0.8×	209 1.4×	70 0.6×	52	2.0k
Dennis O. Adeegbe United States	18	1.2k 0.6×	845 0.5×	487 0.8×	164 1.1×	45 0.4×	31	1.9k
Viktor Fleming Germany	9	1.3k 0.6×	938 0.6×	459 0.8×	179 1.2×	152 1.3×	10	1.8k
Kousaku Mimura Japan	25	1.3k 0.6×	1.5k 1.0×	542 0.9×	172 1.2×	110 1.0×	49	2.3k

Countries citing papers authored by Isabel Poschke

Since Specialization

Citations

This map shows the geographic impact of Isabel Poschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Poschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Poschke more than expected).

Fields of papers citing papers by Isabel Poschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Poschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Poschke. The network helps show where Isabel Poschke may publish in the future.

Co-authorship network of co-authors of Isabel Poschke

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Poschke. A scholar is included among the top collaborators of Isabel Poschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Poschke. Isabel Poschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salek, Mogjiborahman, Jonas P. Becker, Pornpimol Charoentong, et al.. (2024). optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material. Molecular & Cellular Proteomics. 23(9). 100825–100825. 5 indexed citations

Lindner, Katharina A.M., Chin Leng Tan, Kristine Jähne, et al.. (2024). H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient. Science Advances. 10(5). eadi9091–eadi9091. 7 indexed citations

Bunse, Lukas, Khwab Sanghvi, Richard P. Harbottle, et al.. (2023). P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB). Neuro-Oncology. 25(Supplement_2). ii46–ii46. 1 indexed citations

Kilian, Michael, Katrin Aslan, Khwab Sanghvi, et al.. (2022). T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells. Neuro-Oncology Advances. 4(1). vdac140–vdac140. 5 indexed citations

Heilig, Raphael, Isabel Poschke, Michael Volkmar, et al.. (2020). Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Science Signaling. 13(631). 22 indexed citations

Wickström, Stina L., Tanja Lövgren, Michael Volkmar, et al.. (2019). Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display. Frontiers in Immunology. 10. 2766–2766. 22 indexed citations

Giese, Nathalia A., Thomas Giese, Isabel Poschke, et al.. (2014). Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer. Clinical Cancer Research. 20(13). 3422–3433. 167 indexed citations

Coaña, Yago Pico de, Isabel Poschke, Giusy Gentilcore, et al.. (2013). Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production. Cancer Immunology Research. 1(3). 158–162. 110 indexed citations

González, Fermín E., Marcos Ramírez, Andreas Lundqvist, et al.. (2013). Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients. Immunobiology. 219(3). 189–197. 6 indexed citations

10.

Boniface, Jana de, et al.. (2012). Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients. OncoImmunology. 1(8). 1305–1312. 62 indexed citations

11.

Poschke, Isabel & Rolf Kiessling. (2012). On the armament and appearances of human myeloid-derived suppressor cells. Clinical Immunology. 144(3). 250–268. 152 indexed citations

12.

Poschke, Isabel, Dimitrios Mougiakakos, & Rolf Kiessling. (2011). Camouflage and sabotage: tumor escape from the immune system. Cancer Immunology Immunotherapy. 60(8). 1161–1171. 129 indexed citations

13.

Boniface, Jana de, Isabel Poschke, Yumeng Mao, & Rolf Kiessling. (2011). Tumor‐dependent down‐regulation of the ζ‐chain in T‐cells is detectable in early breast cancer and correlates with immune cell function. International Journal of Cancer. 131(1). 129–139. 28 indexed citations

14.

Poschke, Isabel, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, & Rolf Kiessling. (2010). Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign. Cancer Research. 70(11). 4335–4345. 329 indexed citations

15.

Norell, Håkan, Isabel Poschke, Jehad Charo, et al.. (2010). Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial. Journal of Translational Medicine. 8(1). 53–53. 99 indexed citations

16.

Mimura, Kousaku, Takashi Ando, Isabel Poschke, et al.. (2010). T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2. International Journal of Cancer. 128(2). 390–401. 48 indexed citations

17.

Carlsten, Mattias, Håkan Norell, Yenan T. Bryceson, et al.. (2009). Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells. The Journal of Immunology. 183(8). 4921–4930. 224 indexed citations

18.

Kruschinski, Anna, Andreas Moosmann, Isabel Poschke, et al.. (2008). Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas. Proceedings of the National Academy of Sciences. 105(45). 17481–17486. 158 indexed citations

19.

Johansson, C. Christian, Suzanne Egyházi, Giuseppe Masucci, et al.. (2008). Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunology Immunotherapy. 58(7). 1085–1094. 41 indexed citations

20.

Harlin, Helena, Mikael Hanson, C. Christian Johansson, et al.. (2007). The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset. The Journal of Immunology. 179(7). 4513–4519. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact